Conference spotlight and recent stock pressure

NuScale Power (SMR) heads into its World Chemical Forum 2026 presentation on March 26 after a 15.6% share price drop in March tied to disappointing fourth quarter 2025 financial results and softer sentiment.

With project delays and the path to commercial operations under scrutiny, this conference appearance and the upcoming first quarter 2026 results call are likely to shape how investors think about NuScale Power's small modular reactor business and funding needs.

Beyond the recent March pullback, NuScale Power’s share price return is down 49.9% over 90 days and 39.6% year to date. The 3 year total shareholder return is 12.2%, illustrating fading short term momentum versus a still positive multi year record.

If you are weighing NuScale’s nuclear story against other potential opportunities, it can help to scan peers across the sector using our nuclear energy infrastructure stocks screener, starting with 93 nuclear energy infrastructure stocks.

With SMR now trading at US$9.86, sitting well below several analyst targets and carrying a weak recent return profile, the key question is simple: is this a reset that opens a window, or is the market already discounting future growth?

Most Popular Narrative: 1,117.3% Overvalued

According to the most followed narrative, NuScale Power’s fair value sits at $0.81 per share versus the last close at $9.86, a wide gap that frames how some investors view the stock’s risk and reward trade off.

As of today, they are transitioning from an engineering and development phase to commercial deployment. Massive Cash Buffer: NuScale ended 2025 with $1.3 billion in liquidity. This was achieved through an aggressive $750 million share sale (ATM program) in late 2025. This gives them roughly 2 to 3 years of runway at current spending levels.

What justifies such a steep discount in that fair value estimate? The narrative leans heavily on ambitious revenue growth, persistent losses, and a punchy future earnings multiple that assumes a big payoff down the line. The tension between fast top line expansion and ongoing cash burn sits at the core of this story.

Result: Fair Value of $0.81 (OVERVALUED)

However, this bearish setup can be challenged if NuScale addresses the ENTRA1 controversy cleanly and deploys its US$1.3b liquidity without further heavy dilution.

Next Steps

With this mix of pressure and potential, do not wait for the crowd to settle the debate for you. Review the data on both sides and weigh the 1 key reward and 3 important warning signs

Looking for more investment ideas?

If NuScale has you thinking harder about risk and reward, use that momentum to line up a few fresh ideas with stronger starting points and different profiles.

• Target dependable cash generators by scanning companies in the 63 high quality undervalued stocks that combine quality fundamentals with more modest pricing.
• Prioritise resilience by checking out the 73 resilient stocks with low risk scores, focusing on businesses with steadier risk scores that may suit a calmer ride.
• Hunt for future standouts early using the screener containing 24 high quality undiscovered gems, so you are not only hearing about them once they are already crowded trades.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.